-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
News
-
Qualcomm Wins Appeal in Antitrust Suit
August 12, 2020
The Ninth Circuit on August 11, 2020, vacated a 2019 ruling that held that Qualcomm was charging phone makers “unreasonably high” licensing fees and thwarting competition. -
Lab Instrument Maker Beats Suit Over Ex-Employee’s Lamp Tech
August 11, 2020
The US Court of Appeals for the Fifth Circuit on August 7, 2020, held that Petroleum Analyzer Co. (PA), a leading lab instrument maker, didn’t steal a former employee’s trade secrets covering a sulfur-detecting lamp. -
Federal Circuit Affirms Limits on How Government Uses PACER Fees
August 7, 2020
The US Court of Appeals for the Federal Circuit on August 6, 2020, affirmed that the government can use PACER revenues for operating the electronic court record system, but not for unrelated court technology projects. -
Bee Farm Didn’t Infringe Copyright Related to Honey Harvest Tool
August 6, 2020
The US Court of Appeals for the Second Circuit on August 4, 2020, held that a bee farm didn’t infringe a copyright related to a honey harvesting aid when it replaced the tool with its own version. -
Teva Beats Patent Infringement Suit Over Generic Thyroid Drug
August 5, 2020
Teva Pharmaceuticals USA Inc., an American Israeli pharmaceutical company that specializes in generic drugs, beat back IBSA Institut Biochimique’s patent infringement suit concerning the thyroid drug Tirosint.